APP and Alzheimer disease: The discovery of genetic mutations in APP promoting AD pathology (Swedish mutation KM/NL and an Italian variant A673V) and the protective Icelandic (A673T) mutation provide compelling evidence that reducing Aβ production would be beneficial for preventing AD development [3,4,5].